Drugs / KLA480
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07030790 | May 2025 → Dec 2026 expected | — | Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KLA480 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07030790 ↗ |
| Route | Subcutaneous | “Subcutaneous injection，Single dose” NCT07030790 ↗ |